InvestorsHub Logo
icon url

vinmantoo

08/10/23 2:45 PM

#4067 RE: DewDiligence #4066

You should cease injecting patients until you figure this out, IMO.



Perhaps his practice should ask RVNC for more training rather than trying to figure it out on their own. We do have to consider that it was a small sample size he reported.
icon url

10nisman

08/10/23 2:46 PM

#4068 RE: DewDiligence #4066

I believe we are most likely an outlier. But we aren’t sure why.

Probably because he's spending a bunch of time posting messages and not enough time focused on patients.
icon url

Dennboy66

08/10/23 3:01 PM

#4071 RE: DewDiligence #4066

Frankly, he has a duty to report this to the company so that they can investigate. They will assign an MSL - Medical Science Liaison for a meeting. He knows this. You can't just post adverse events on a message board. The company needs to investigate his practice utilization. Especially since he is a "National Account". The company needs to have and opportunity to protect themselves from this type of "negative" comments.